Omega 3-PUFA Market Analysis by Mordor Intelligence
The omega-3 PUFA market was valued at USD 2.76 billion in 2025 and is forecast to reach USD 3.88 billion by 2030, advancing at a steady 7.05% CAGR. This growth is driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids, including their role in reducing inflammation and supporting overall well-being. Heightened concerns over cardiovascular and cognitive health, backed by expanding clinical evidence and favorable regulations, solidify consumer trust in omega-3 fortified products. While marine oils continue to dominate, there's a swift rise in plant-based alternatives, driven by sustainability considerations. Key economies, particularly China and the European Union, are modernizing regulations, hastening product development cycles and raising quality standards. Additionally, advancements in extraction technologies and the development of innovative delivery formats, such as gummies and soft gels, are further fueling market expansion.
Key Report Takeaways
- By product type, marine-derived ingredients led with 75.11% revenue share in 2024; plant-based sources are poised to expand at an 8.48% CAGR to 2030.
- By type, DHA accounted for 42.47% of the omega-3 PUFA market share in 2024, while the EPA segment is projected to grow at 8.08% CAGR through 2030.
- By application, food and beverages contributed 36.34% of the omega-3 PUFA market size in 2024 and pharmaceuticals are advancing at a 7.87% CAGR.
- By geography, North America captured 31.22% of the omega-3 PUFA market in 2024; Asia-Pacific is registering the fastest pace at 9.04% CAGR.
Global Omega 3-PUFA Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Growth of Omega-3 Enriched Food and Beverage Products to Support Cardiovascular Health | +1.8% | Global, with early gains in North America, Europe | Medium term (2-4 years) |
Rising Consumer shift Towards Preventive Healthcare | +1.5% | Global, particularly strong in Asia-Pacific, North America | Long term (≥ 4 years) |
High Adoption in Dietary Supplements and Functional Nutrition | +1.2% | North America and Europe core, spill-over to Asia-Pacific | Short term (≤ 2 years) |
Surge in Cognitive Health Supplement Among Aging Population | +1.0% | Global, concentrated in developed markets | Medium term (2-4 years) |
Increased Application in Animal and Pet Feed | +0.8% | Global, with strong growth in Asia-Pacific aquaculture | Medium term (2-4 years) |
Widespread Adoption in Functional Bakery and Dairy Products | +0.7% | Europe and North America, expanding to Asia-Pacific | Long term (≥ 4 years) |
Source: Mordor Intelligence
Growth of Omega-3 Enriched Food and Beverage Products to Support Cardiovascular Health
The increasing demand for omega-3-enriched food and beverage products is a significant driver of the global omega-3 PUFA market. These products are widely recognized for their role in supporting cardiovascular health, as omega-3 fatty acids help reduce triglyceride levels, lower blood pressure, and improve overall heart health. According to the American Heart Association (AHA), omega-3 fatty acids, particularly EPA and DHA, are essential for maintaining cardiovascular health and reducing the risk of heart disease[1]Source: American Heart Association, "Are you getting enough omega-3 fatty acids?", www.heart.org. Governments and health organizations worldwide are actively promoting the consumption of omega-3-rich diets. For instance, the Dietary Guidelines for Americans recommend regular consumption of seafood, a primary source of omega-3 fatty acids, to meet nutritional requirements. Furthermore, the European Food Safety Authority (EFSA) has approved health claims linking omega-3 fatty acids to heart health, further driving consumer awareness and demand for enriched products.
Rising Consumer Shift Towards Preventive Healthcare
Consumers are increasingly prioritizing preventive healthcare measures, which is fueling the market growth. Preventive healthcare focuses on maintaining health and preventing diseases rather than treating them after they occur. According to the World Health Organization (WHO), non-communicable diseases (NCDs), such as cardiovascular diseases and diabetes, account for 74% of all global deaths [2]Source: World Health Organization, "Noncommunicable diseases", www.who.int. This has led to a growing awareness among consumers about the importance of incorporating essential nutrients, like Omega-3 PUFAs, into their diets to reduce the risk of such conditions. Additionally, the U.S. Department of Health and Human Services highlights the role of Omega-3 fatty acids in supporting heart health and reducing inflammation, further encouraging their adoption. This shift in consumer behavior is expected to significantly contribute to the market's growth during the forecast period.
High Adoption in Dietary Supplements and Functional Nutrition
The market is experiencing significant growth, driven by the increasing adoption of dietary supplements and functional nutrition. Consumers are becoming more health-conscious, leading to a higher demand for omega-3 fatty acids, which are known for their numerous health benefits, including improved heart health, brain function, and reduced inflammation. According to the National Institutes of Health (NIH), omega-3 fatty acids are essential nutrients that play a crucial role in maintaining overall health. Additionally, the World Health Organization (WHO) emphasizes the importance of omega-3 intake in reducing the risk of chronic diseases. This growing awareness, coupled with the rising prevalence of lifestyle-related disorders such as cardiovascular diseases and obesity, is propelling the demand for omega-3 PUFA in dietary supplements and functional foods. These endorsements from credible organizations are encouraging consumers to incorporate omega-3 supplements and functional foods into their daily routines.
Surge in Cognitive Health Supplement Among Aging Population
The rising demand for cognitive health supplements among the aging population is a key driver of the market. With the global population aged 60 years and above projected to reach 2.1 billion by 2050, according to the World Health Organization [3]Source: World Health Organization, "Ageing and health", www.who.int, the need for products supporting brain health is increasing. Omega-3 PUFAs, particularly DHA (docosahexaenoic acid), are widely recognized for their role in maintaining cognitive function and reducing the risk of neurodegenerative diseases such as Alzheimer's. Furthermore, the National Institutes of Health (NIH) highlights the importance of Omega-3 fatty acids in supporting overall brain health, particularly in older adults. This growing awareness, coupled with the increasing prevalence of age-related cognitive decline, is driving the adoption of Omega-3 PUFA supplements. As the aging population continues to grow, the demand for cognitive health supplements, including Omega-3 PUFAs, is expected to rise significantly during the forecast period.
Restraints Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Unpleasant Odor and Taste in marine Derived Omega-3s | -1.2% | Global, particularly affecting consumer products | Short term (≤ 2 years) |
Stringent Regulatory Approvals | -0.8% | Europe and North America, emerging in Asia-Pacific | Medium term (2-4 years) |
Concern Regarding Overfishing and Marine Ecosystem Damage | -0.6% | Global, with regulatory focus in Europe and North America | Long term (≥ 4 years) |
Complexity in Bioavailability and Absorption Among Different Types | -0.4% | Global, affecting all market segments | Medium term (2-4 years) |
Source: Mordor Intelligence
Unpleasant Odor and Taste in Marine Derived Omega-3s
The unpleasant odor and taste associated with marine-derived omega-3 products pose a significant challenge in the global omega-3 PUFA market. These sensory issues often result from the oxidation of omega-3 fatty acids, which can lead to a fishy smell and taste, making the products less appealing to consumers. This restraint impacts the adoption of omega-3 supplements, particularly among individuals sensitive to such sensory attributes. Manufacturers are investing in advanced encapsulation technologies and flavor-masking techniques to address this issue, but the challenge persists as a critical factor influencing consumer preferences and market growth. The taste and odor challenge creates market opportunities for algae-based alternatives, though marine sources maintain cost advantages and established supply chains that complicate rapid substitution across price-sensitive segments. Overcoming this restraint is essential for expanding the market penetration of marine-derived omega-3 products.
Stringent Regulatory Approvals
Stringent regulatory approvals act as a significant restraint in the market. The regulatory landscape for omega-3 PUFA products is becoming increasingly complex, with governments and regulatory bodies imposing rigorous standards to ensure product safety, efficacy, and quality. These regulations often require extensive clinical trials, detailed documentation, and compliance with strict labeling and manufacturing guidelines. Such requirements can lead to increased costs and extended timelines for product development and market entry, posing challenges for manufacturers. Furthermore, the approval process for omega-3 PUFA products varies significantly across regions, with each country or region having its own set of regulatory requirements. For instance, the European Union has stringent guidelines under the European Food Safety Authority (EFSA), while the United States Food and Drug Administration (FDA) mandates rigorous testing and approval processes. Overall, stringent regulatory approvals not only increase the operational burden on manufacturers but also create barriers to innovation and market expansion. These factors collectively hinder the growth potential of the omega-3 PUFA market during the forecast period.
Segment Analysis
By Product Type: Marine Dominance Faces Plant-Based Disruption
Marine-derived oils held a dominant 75.11% share of the omega-3 PUFA market in 2024. This dominance is attributed to their well-established supply chains, competitive cost structures, and high concentrations of EPA and DHA, which are critical for various health benefits. The market size for marine oils is expected to grow in line with the increasing global demand for omega-3 PUFAs. However, their relative market share is anticipated to decline as plant-based alternatives continue to gain traction, driven by shifting consumer preferences and sustainability concerns.
Plant-based omega-3 solutions are experiencing rapid growth, with a robust CAGR of 8.48%. This growth is fueled by the rising adoption of vegan lifestyles and increasing awareness of environmental sustainability. A notable development in this segment is DSM-Firmenich's introduction of life’sOMEGA, the first plant-based ingredient to deliver both EPA and DHA, effectively addressing a longstanding nutritional gap in the market. The innovation and expanding availability of plant-based alternatives are expected to significantly influence the competitive dynamics of the omega-3 PUFA market in the coming years.

Note: Segment shares of all individual segments available upon report purchase
By Type: DHA Leadership Challenged by EPA’s Clinical Momentum
In 2024, DHA held a significant 42.47% share of the omega-3 PUFA market. This dominance is primarily driven by global mandates requiring the inclusion of DHA in infant formulas, which underscores its critical role in early childhood development. Decades of research have consistently highlighted DHA's importance in supporting cognitive health, particularly in brain and eye development. The increasing awareness of these benefits has led to a surge in demand for DHA-enriched products, not only in infant nutrition but also in dietary supplements and functional foods targeted at adults and the aging population.
EPA, on the other hand, is emerging as a key growth driver within the omega-3 PUFA market, registering an impressive CAGR of 8.08%. The rising prevalence of cardiovascular diseases globally has amplified the demand for EPA, as numerous randomized clinical trials have demonstrated its significant cardiovascular benefits, including reducing inflammation and improving heart health. EPA-focused products are increasingly gaining traction among health-conscious consumers, particularly those seeking targeted solutions for heart health and overall wellness. Additionally, the growing adoption of EPA in pharmaceutical formulations and its expanding applications in functional foods and beverages are expected to further drive its market growth.
By Application: Food and Beverages Lead While Pharmaceuticals Accelerate
In 2024, food and beverage sales accounted for 36.34% of total sales, driven by manufacturers reformulating cereals, dairy products, and ready meals in response to the FDA's updated "healthy" definition. The reformulation efforts aim to align with consumer demand for healthier options, which has been further influenced by regulatory changes. This trend highlights the growing emphasis on nutritional value and transparency in the food and beverage market, positioning it as a significant contributor to the Omega-3 PUFA market's growth. Additionally, the incorporation of Omega-3 PUFA into functional foods and beverages, such as fortified juices, milk, and snacks, is gaining traction. This is driven by increasing consumer awareness of Omega-3's health benefits, including improved heart health, brain function, and overall wellness.
Meanwhile, the pharmaceutical sector is outpacing with a robust 7.87% CAGR. The sector's growth is fueled by the increasing adoption of Omega-3 PUFA in the development of drugs targeting cardiovascular health, mental well-being, and inflammatory conditions. The rising prevalence of chronic diseases, such as heart disease and arthritis, coupled with growing awareness of Omega-3's therapeutic benefits, is driving pharmaceutical manufacturers to integrate these fatty acids into their product portfolios. Furthermore, the pharmaceutical market is witnessing advancements in Omega-3 formulations, including prescription-grade products and innovative delivery systems, such as soft gels and capsules, to enhance bioavailability and patient compliance.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
In 2024, North America holds a dominant 31.22% share of the market, bolstered by its advanced regulatory frameworks, a well-entrenched culture of supplements, and a robust clinical research infrastructure that underscores the health benefits of omega-3s. The region enjoys a favorable market landscape, thanks to the FDA's progressive approach towards qualified health claims and its revised definition of "healthy" labeling, which now encompasses omega-3-rich foods. These regulatory advancements not only encourage product innovation but also enhance consumer confidence and adoption, creating a thriving environment for omega-3 products.
Meanwhile, the Asia-Pacific region is on a rapid ascent, projected to grow at a 9.04% CAGR through 2030. This surge is fueled by an uptick in health consciousness, a move towards regulatory harmonization, and a burgeoning middle class in pivotal markets. China's recent move to include DHA in its Health Food Raw Materials Directory, stipulating a daily intake limit of 200-1000mg for adults, underscores a maturing regulatory landscape that's poised to bolster market growth. Additionally, Japan and South Korea continue to lead with the highest global omega-3 index scores, reflecting their strong consumer awareness and established consumption patterns. In contrast, Chinese consumers are increasingly showing interest in fish oils, signaling a growing market potential despite their historically lower baseline consumption levels.
Europe is witnessing consistent growth, driven by initiatives centered on sustainability and the approval of novel foods. The EFSA's recent guidance updates have further smoothed the path for innovative omega-3 sources to enter the market. These measures align with the region's focus on environmental responsibility and consumer safety, ensuring steady market expansion. Meanwhile, South America and the Middle East and Africa are emerging as promising frontiers. In Brazil, ANVISA has rolled out updates to food supplement regulations, aimed at improving product standards and market accessibility. Similarly, Saudi Arabia is advancing its nutritional labeling standards, which could significantly enhance omega-3 market access and consumer awareness in the region. Both regions present untapped opportunities for growth, driven by evolving regulatory landscapes and increasing consumer interest in health and wellness products.

Competitive Landscape
The omega-3 PUFA market is moderately fragmented, is characterized by a balanced dynamic created by established marine oil producers and emerging algae-based innovators. The market has witnessed significant strategic consolidations, which are reshaping its structure. For instance, Louis Dreyfus Company's acquisition of BASF's food and health ingredients business and KD Pharma Group's purchase of DSM-Firmenich's marine lipids operations, including the MEG-3 brand and production facilities in Peru and Canada, are notable examples. These acquisitions reflect a growing trend of vertical integration, enabling companies to secure control over their supply chains while expanding their geographic presence and technological capabilities.
Innovation plays a pivotal role in intensifying competition within the market. Companies are increasingly focusing on bioavailability enhancement technologies to improve the efficacy of omega-3 PUFA products. For example, advancements in microencapsulation techniques and emulsification processes are being adopted to enhance the absorption of omega-3 fatty acids in the human body. Additionally, sustainable sourcing initiatives are gaining traction, with companies exploring algae-based omega-3 production as an alternative to traditional fish oil. This shift not only addresses environmental concerns but also ensures a steady supply of raw materials, reducing dependency on marine resources.
Furthermore, the market is witnessing collaborations and partnerships aimed at driving innovation and expanding product portfolios. For instance, partnerships between biotechnology firms and omega-3 manufacturers are fostering the development of novel products tailored to specific consumer needs, such as vegan omega-3 supplements. The competitive landscape is also influenced by regional players who are leveraging local resources and expertise to cater to domestic demand. These dynamics collectively contribute to a vibrant and evolving market environment, where companies are striving to differentiate themselves through innovation, sustainability, and strategic growth initiatives.
Omega 3-PUFA Industry Leaders
-
Cargill, Incorporated
-
BASF SE
-
Archer Daniels Midland Company
-
DSM-Firmenich AG
-
Corbion N.V.
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2025: Epax announced USD 10 million investment to boost omega-11 production capabilities, signaling expansion beyond traditional EPA/DHA focus into emerging omega fatty acid variants. Omega-11 has been studied for its ability to convert the plant-based omega-3 alpha-lipoic acid (ALA) into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells.
- December 2024: Louis Dreyfus Company completed acquisition of BASF's food and health performance ingredients business, expanding capabilities in omega-3 ingredient manufacturing and distribution across global markets.
- October 2024: DSM-Firmenich launched life's DHA B54-0100, a high-potency algae-derived omega-3 ingredient providing 545mg DHA and 80mg EPA per gram, enabling smaller capsule formulations and eliminating fishy odors for gummy applications.
- October 2024: CoreFX has launched a new range of omega powders, branded as CoreNhanced, featuring EPA, DHA, ALA, and SDA oils sourced from fish, algae, flax, and Ahiflower. These omega powders are designed to provide a versatile and convenient solution for incorporating essential fatty acids into various applications, catering to the growing demand for functional and nutritional ingredients in the food and beverage industry.
Global Omega 3-PUFA Market Report Scope
The global omega-3 PUFA market has been segmented by source into plant and marine sources; and by type into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-Linolenic Acid (ALA), and others. By concentration, the market is segmented into high concentration, medium concentration, and low concentration; and by application into food and beverage, dietary supplements, pharmaceuticals, and animal feed. The market is also segmented by geography into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The report offers market size and forecasts for the organic food and beverages market in value (USD million) for all the above segments.
By Product Type | Plant | ||
Marine | |||
By Type | Docosahexanoic acid (DHA) | ||
Eicosapentanoic acid (EPA) | |||
Alpha-Linolenic Acid (ALA) | |||
Others | |||
By Application | Food and Beverages | ||
Dietary Supplements | |||
Pharmaceutical | |||
Animal Feed | |||
Others | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Europe | Germany | ||
United Kingdom | |||
Italy | |||
France | |||
Spain | |||
Poland | |||
Rest of Europe | |||
Asia-Pacific | China | ||
India | |||
Japan | |||
Australia | |||
Rest of Asia-Pacific | |||
South America | Brazil | ||
Argentina | |||
Rest of South America | |||
Middle East and Africa | South Africa | ||
Saudi Arabia | |||
United Arab Emirates | |||
Rest of Middle East and Africa |
Plant |
Marine |
Docosahexanoic acid (DHA) |
Eicosapentanoic acid (EPA) |
Alpha-Linolenic Acid (ALA) |
Others |
Food and Beverages |
Dietary Supplements |
Pharmaceutical |
Animal Feed |
Others |
North America | United States |
Canada | |
Mexico | |
Rest of North America | |
Europe | Germany |
United Kingdom | |
Italy | |
France | |
Spain | |
Poland | |
Rest of Europe | |
Asia-Pacific | China |
India | |
Japan | |
Australia | |
Rest of Asia-Pacific | |
South America | Brazil |
Argentina | |
Rest of South America | |
Middle East and Africa | South Africa |
Saudi Arabia | |
United Arab Emirates | |
Rest of Middle East and Africa |
Key Questions Answered in the Report
What is the projected size of the omega-3 PUFA market by 2030?
The omega-3 PUFA market is expected to reach USD 3.88 billion by 2030, supported by a 7.05% CAGR.
Which product type currently dominates the omega-3 PUFA market?
Marine-derived oils lead with 75.11% share due to mature supply chains and high EPA/DHA concentrations.
Why are plant-based omega-3 sources growing faster than marine oils?
Plant sources offer sustainability advantages, meet vegan preferences, and alleviate overfishing concerns, resulting in an 8.48% CAGR.
Which region shows the highest growth rate for omega-3 products?
Asia-Pacific is expanding the fastest at 9.04% CAGR, driven by rising health awareness and supportive regulations.
What are the main restraints facing the omega-3 PUFA market?
Sensory issues with marine oils, stringent regulatory approvals, and ecosystem sustainability concerns are the key hurdles.
Page last updated on: July 3, 2025